Researchers in the College of Pharmacy say compounds targeting proteins involved in viral replication may further drug development for treating COVID-19.

A study investigating a personalized cancer vaccine has reported a 50% response rate for patients with head and neck cancer in its preliminary data.

In pre-clinical studies, researchers found that low-dose ketamine infusions can improve pain, depression and levodopa-induced dyskinesia in Parkinson's patients.

As coronavirus cases grow in Arizona, the state could reach a “crisis point” after Thanksgiving, one expert recently warned. “I don’t see us reaching any particular crisis point before Thanksgiving,” Dr. Joe Gerald, an associate professor with the University of Arizona’s Zuckerman College of Public Health, told the Arizona Daily Star.

Joe Gerald, an associate professor at the University of Arizona's Mel and Enid Zuckerman College of Public Health and an epidemiologist working on modeling the COVID-19 pandemic, has been named to Arizona Sen.-elect Mark Kelly's 13-person bipartisan transition team.

The trial for the vaccine still needs to be completed. The No. 1 priority is making sure the vaccine is safe, because even a rare side effect could hurt thousands. Dr. Jun Wang, an associate professor in the Department of Pharmacology and Toxicology at the University of Arizona College of Pharmacy said, “We should be excited, but there is way more work to do."

A new study by researchers at the University of South Florida Health Morsani College of Medicine and the University of Arizona College of Pharmacy, offers insight into designing antiviral drugs against COVID-19.

To figure out how holiday gatherings can be adapted so that possible transmission of COVID-19 is less likely, the Arizona Republic spoke with Dr. Kelly Reynolds, an expert on disease transmission and professor at UA’s Mel and Enid Zuckerman College of Public Health.

Health experts said President-elect Joe Biden's plan is a stark contrast to the current administration's handling of the pandemic. "This administration hasn't had any comprehensive plan as far as I can tell, in terms of a comprehensive testing strategy," said Dr. Shad Marvasti, director of public health, prevention and health promotion with the University of Arizona College of Medicine – Phoenix. "I am just really excited and hopeful."